Which laboratory tests should be ordered for a woman who experienced a miscarriage in her most recent pregnancy?

Laboratory Testing After Miscarriage

For a woman who experienced a miscarriage in her most recent pregnancy, the essential immediate laboratory test is a urinary pregnancy test 3 weeks post-miscarriage to ensure hCG normalization, with tissue pathology examination if not already performed 1.

Immediate Post-Miscarriage Testing

Primary Requirement

• Urinary pregnancy test at 3 weeks post-miscarriage to confirm hCG resolution 1
  • If positive, obtain serum hCG levels and track serially to ensure declining values
  • If hCG plateaus or rises, arrange ultrasound to evaluate for retained tissue or gestational trophoblastic disease (GTD)
  • Persistent elevation warrants referral to a GTD center 1

Tissue Pathology (Critical if Not Done)

• All pregnancy tissue should undergo histological examination when no fetal parts were identified 1
  • Excludes gestational trophoblastic neoplasia (incidence 2.7% in unrecognized cases)
  • Particularly important if the miscarriage was managed medically or surgically without prior tissue analysis

Workup for Future Pregnancy Planning

The evidence provided focuses primarily on prenatal screening during ongoing pregnancies and GTD surveillance rather than recurrent pregnancy loss evaluation. However, based on the research evidence and clinical context:

If This Was a Single Miscarriage

• No extensive workup is typically indicated after one isolated miscarriage
• Ensure the pregnancy test normalizes as above
• Standard preconception counseling for future pregnancy

If Considering Recurrent Loss Evaluation (≥2 miscarriages)

While not explicitly covered in the guideline evidence provided, the research studies suggest:

Coagulation Assessment:

• APTT (activated partial thromboplastin time) - prolonged values independently associated with both missed abortion and recurrent spontaneous abortion 2, 3
• Thrombin time (TT) and fibrinogen (FBG) - combination with APTT shows predictive value (AUC 0.831) 3
• Protein C, Protein S, Antithrombin III - deficiencies found in 42.7% of women with recurrent loss, with protein C deficiency most prevalent (30.5%) 4
• Lupus anticoagulant - abnormal in 8.5% of recurrent loss cases 4

Thyroid Function:

• TSH and Free T4 - thyroid dysfunction found in 66.67% of women with history of fetal death 5
• Subclinical hypothyroidism most common abnormality (25% overall prevalence in at-risk populations) 6, 5

Other Considerations:

• Karyotyping of pregnancy tissue (if available from the miscarriage) - chromosomal abnormalities are the leading cause of first-trimester loss
• Parental karyotyping may be considered in recurrent loss scenarios

Critical Pitfalls to Avoid

1. Do not assume hCG normalization without testing - failure to diagnose GTD leads to significantly worse outcomes including life-threatening complications and need for hysterectomy 1

2. Do not skip tissue pathology when fetal parts were not identified - 2.7% incidence of unrecognized GTD 1

3. Refer promptly if hCG remains elevated after excluding ectopic pregnancy or after two methotrexate treatments for pregnancy of unknown location 1

4. Do not order extensive thrombophilia or endocrine panels after a single miscarriage - this represents overtreatment as single miscarriages are common (15-20% of pregnancies)

The most recent and highest-quality guideline evidence 1, 7, 1 consistently emphasizes post-miscarriage hCG surveillance and tissue pathology as the priority interventions to prevent serious complications from unrecognized GTD, which takes precedence over speculative workups for future pregnancy loss.